Search details
1.
Lowering barriers to naloxone access through a student-led harm reduction program.
J Am Pharm Assoc (2003)
; 63(1): 349-355, 2023.
Article
in English
| MEDLINE | ID: mdl-36443177
2.
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
Harm Reduct J
; 19(1): 69, 2022 06 29.
Article
in English
| MEDLINE | ID: mdl-35768817
3.
Prevalence and distribution of high-risk prescription opioid use in the United States, 2011-2016.
Pharmacoepidemiol Drug Saf
; 30(11): 1532-1540, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34435406
4.
Adverse childhood experiences among California student pharmacists.
Ment Health Clin
; 14(1): 1-9, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38312442
5.
Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy.
Arch Public Health
; 82(1): 58, 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38664777
6.
Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects.
Ther Adv Drug Saf
; 14: 20420986231213173, 2023.
Article
in English
| MEDLINE | ID: mdl-38074415
7.
Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later.
J Addict Med
; 17(1): e64-e66, 2023.
Article
in English
| MEDLINE | ID: mdl-35839323
8.
Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic.
Drug Alcohol Depend
; 232: 109291, 2022 03 01.
Article
in English
| MEDLINE | ID: mdl-35033953
9.
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
Am J Health Syst Pharm
; 78(7): 613-618, 2021 03 18.
Article
in English
| MEDLINE | ID: mdl-33411894
10.
Dissociating the Clinical Role and Economic Value of Intranasal Esketamine.
J Manag Care Spec Pharm
; 26(1): 20-22, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31880233
11.
Safety of Repeated Administration of Parenteral Ketamine for Depression.
Pharmaceuticals (Basel)
; 13(7)2020 Jul 13.
Article
in English
| MEDLINE | ID: mdl-32668686
12.
The effects of ketamine on suicidality across various formulations and study settings.
Ment Health Clin
; 9(1): 48-60, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30627504
13.
Using the LACE Score as a Predictor of Clinical Outcomes in Patients Referred for Inpatient Palliative Care Consultation: A Single-Center Experience.
Am J Hosp Palliat Care
; : 1049909118793177, 2018 Jul 31.
Article
in English
| MEDLINE | ID: mdl-30064238
Results
1 -
13
de 13
1
Next >
>>